Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000185955 | SCV000238912 | uncertain significance | not provided | 2020-08-03 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001037955 | SCV001201393 | likely benign | Holocarboxylase synthetase deficiency | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003298244 | SCV003995098 | uncertain significance | Inborn genetic diseases | 2023-05-30 | criteria provided, single submitter | clinical testing | The c.889C>T (p.R297W) alteration is located in exon 5 (coding exon 2) of the HLCS gene. This alteration results from a C to T substitution at nucleotide position 889, causing the arginine (R) at amino acid position 297 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |